Beijing Health (Holdings) Limited (HKG:2389)
Hong Kong · Delayed Price · Currency is HKD 0.0630
0.00 (0.00%)
At close: Feb 13, 2026
Beijing Health (Holdings) Income Statement
Financials in millions HKD. Fiscal year is January - December.
Millions HKD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| 153.23 | 149.95 | 140.35 | 166.48 | 203.78 | 149.89 | |
Revenue Growth (YoY) | 12.98% | 6.84% | -15.70% | -18.30% | 35.95% | -25.34% |
Cost of Revenue | 113.53 | 114.27 | 101.87 | 119.97 | 165.21 | 117.1 |
Gross Profit | 39.69 | 35.68 | 38.47 | 46.51 | 38.57 | 32.79 |
Selling, General & Admin | 96.31 | 95.05 | 103.38 | 111.96 | 116.03 | 131.8 |
Operating Expenses | 95.18 | 95.47 | 104.38 | 115.7 | 114.68 | 131.61 |
Operating Income | -55.49 | -59.79 | -65.9 | -69.19 | -76.12 | -98.82 |
Interest Expense | -0.27 | -0.23 | -0.38 | -1.44 | -2.07 | -1.94 |
Interest & Investment Income | 20.56 | 12.49 | 23.11 | 27.5 | 36.62 | 37.78 |
Earnings From Equity Investments | -28.19 | -30.43 | -23.02 | -43.5 | -17.89 | -43.28 |
Currency Exchange Gain (Loss) | 2.45 | -29.29 | 9.24 | - | 4.03 | 0.33 |
Other Non Operating Income (Expenses) | 10.08 | 12.28 | 1.53 | -11.22 | 0.52 | -30.78 |
EBT Excluding Unusual Items | -50.86 | -94.98 | -55.42 | -97.84 | -54.89 | -136.71 |
Gain (Loss) on Sale of Investments | -11.71 | -10.45 | 1.48 | -0.64 | 19.11 | -22.9 |
Gain (Loss) on Sale of Assets | -0.05 | -0.05 | -0.07 | 0.66 | - | -18.73 |
Asset Writedown | -11.63 | -13.89 | -12.15 | -4.88 | -2.41 | -2.7 |
Other Unusual Items | -15.14 | -0.05 | -2.61 | - | -8.43 | -19.68 |
Pretax Income | -89.39 | -119.42 | -68.78 | -102.7 | -46.62 | -200.71 |
Income Tax Expense | -2.08 | -3.85 | -7.06 | -3.89 | -6.39 | -0.72 |
Earnings From Continuing Operations | -87.31 | -115.58 | -61.72 | -98.81 | -40.23 | -199.99 |
Net Income to Company | -87.31 | -115.58 | -61.72 | -98.81 | -40.23 | -199.99 |
Minority Interest in Earnings | -1.74 | -0.64 | -0.16 | 1.11 | 0.82 | 14.67 |
Net Income | -89.04 | -116.22 | -61.88 | -97.7 | -39.41 | -185.32 |
Net Income to Common | -89.04 | -116.22 | -61.88 | -97.7 | -39.41 | -185.32 |
Shares Outstanding (Basic) | 6,059 | 6,059 | 6,059 | 6,070 | 6,079 | 6,079 |
Shares Outstanding (Diluted) | 6,059 | 6,059 | 6,059 | 6,070 | 6,079 | 6,079 |
Shares Change (YoY) | - | - | -0.18% | -0.15% | - | 0.14% |
EPS (Basic) | -0.01 | -0.02 | -0.01 | -0.02 | -0.01 | -0.03 |
EPS (Diluted) | -0.01 | -0.02 | -0.01 | -0.02 | -0.01 | -0.03 |
Free Cash Flow | 5.13 | -42.2 | -45.1 | -34.4 | -22.81 | -4.51 |
Free Cash Flow Per Share | 0.00 | -0.01 | -0.01 | -0.01 | -0.00 | -0.00 |
Gross Margin | 25.91% | 23.79% | 27.41% | 27.94% | 18.93% | 21.88% |
Operating Margin | -36.21% | -39.88% | -46.96% | -41.56% | -37.35% | -65.93% |
Profit Margin | -58.11% | -77.51% | -44.09% | -58.68% | -19.34% | -123.64% |
Free Cash Flow Margin | 3.35% | -28.15% | -32.13% | -20.66% | -11.19% | -3.01% |
EBITDA | -51.66 | -55.86 | -61.34 | -64.03 | -65.77 | -88.13 |
EBITDA Margin | -33.72% | -37.25% | -43.71% | -38.46% | -32.28% | -58.80% |
D&A For EBITDA | 3.83 | 3.94 | 4.56 | 5.15 | 10.35 | 10.69 |
EBIT | -55.49 | -59.79 | -65.9 | -69.19 | -76.12 | -98.82 |
EBIT Margin | -36.21% | -39.88% | -46.96% | -41.56% | -37.35% | -65.93% |
Advertising Expenses | - | 3.74 | 2.75 | 2.24 | 1.72 | 0.82 |
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.